Fidelity International’s Kindred Biosciences, Inc. KIN Stock Holding History

Fidelity International’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,810,000	Closed	-$16.6M	–	922
2021 Q2	$16.6M	Buy	+1,810,000	New	+$10.5M	0.02%	485

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Fidelity International's KIN Position: Q3 2021 in Review

Fidelity International sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,810,000 shares — an estimated $16.6M sold.

Fidelity International first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $16.6M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Fidelity International reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Fidelity International sold 1,810,000 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $16.6M.
Fidelity International first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
Fidelity International's Kindred Biosciences, Inc. position peaked at $16.6M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Fidelity International's 13F filing for Q3 2021, filed 15 Nov 2021.